Ovarian Cancer Screening Unnecessary for Most Women, Consensus Panel Says
In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR
Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center
AMA Anti-Tobacco, Stop-Smoking Program Uses TV Marketing
Cancer Meetings Listed
Komen Foundation Breast Cancer Awards
Letters to the Editor: Love on Mammography; Freireich, Holland On Bernard Fisher
Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - ACS strengthens recommendation for prostate cancer screening
Many will hear the endorsement and ignore the limitations - Kay “Taddy” Dickersin, NBCC co-founder, dies at 74
- CMS rule cuts overall oncology payments by estimated 2%
Final rule slashes 340B, moves toward site-neutrality - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives









